tezepelumab-ekko 210 MG in 1.91 ML Prefilled Syringe

RxCUI: 2587803
RxNorm name: tezepelumab-ekko 210 MG in 1.91 ML Prefilled Syringe
Display name: tezepelumab-ekko 210 MG in 1.91 ML Prefilled Syringe
Full name: tezepelumab-ekko 210 MG in 1.91 ML Prefilled Syringe
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:39:00

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLA	Proprietary name	Proper name	License type	Status	Latest source
761224	Tezspire	tezepelumab-ekko	351(a)	Rx	2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
TEZSPIRE	TEZEPELUMAB-EKKO	Amgen Inc	60f0aa03-ad25-4d48-80ce-7fcfa76f325f	2025-10-17	Warnings, Adverse reactions	Exact identifier rxcui: 2587803

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
60f0aa03-ad25-4d48-80ce-7fcfa76f325f	tezepelumab-ekko 210 MG in 1.91 ML Prefilled Syringe	PSN	15	These highlights do not include all the information needed to use TEZSPIRE safely and effectively. See full prescribing information for TEZSPIRE. TEZSPIRE ® (tezepelumab-ekko) injection, for subcutaneous use Initial U.S. Approval: 2021	20251017
60f0aa03-ad25-4d48-80ce-7fcfa76f325f	tezepelumab-ekko 210 MG per 1.91 ML Prefilled Syringe	SY	15	These highlights do not include all the information needed to use TEZSPIRE safely and effectively. See full prescribing information for TEZSPIRE. TEZSPIRE ® (tezepelumab-ekko) injection, for subcutaneous use Initial U.S. Approval: 2021	20251017
60f0aa03-ad25-4d48-80ce-7fcfa76f325f	1.91 ML tezepelumab-ekko 110 MG/ML Prefilled Syringe	SCD	15	These highlights do not include all the information needed to use TEZSPIRE safely and effectively. See full prescribing information for TEZSPIRE. TEZSPIRE ® (tezepelumab-ekko) injection, for subcutaneous use Initial U.S. Approval: 2021	20251017